TY - JOUR
T1 - The OMERACT ultrasound working group 10 years on: Update at OMERACT 12
AU - Bruyn, George A.
AU - Naredo, Esperanza
AU - Iagnocco, Annamaria
AU - Balint, Peter V.
AU - Backhaus, Marina
AU - Gandjbakhch, Frederique
AU - Gutierrez, Marwin
AU - Filer, Andrew
AU - Finzel, Stephanie
AU - Ikeda, Kei
AU - Kaeley, Gurjit S.
AU - Magni Manzoni, Silvia
AU - Ohrndorf, Sarah
AU - Pineda, Carlos
AU - Richards, Bethan
AU - Roth, Johannes
AU - Schmidt, Wolfgang A.
AU - Terslev, Lene
AU - D'Agostino, Maria Antonietta
AU - Aegerter, Philippe
AU - Aydin, Sibel
AU - Bong, David
AU - Chary-Valckenaere, Isabelle
AU - Collado, Paz
AU - De Miguel, Eugenio
AU - Dejaco, Christian
AU - Epis, Oscar
AU - Freeston, Jane E.
AU - Grassi, Walter
AU - Hanova, Petra
AU - Jousse-Joulin, Sandrine
AU - Joshua, Fredrick
AU - Koski, Juhani
AU - Loeuille, Damien
AU - Möller, Ingrid
AU - Ravagnani, Viviana
AU - Reginato, Anthony
AU - Sharp, Veronica
AU - Swen, Nanno
AU - Szkudlarek, Marcin
AU - Wakefield, Richard J.
AU - Ziswiler, Hans-Rudolf
PY - 2015
Y1 - 2015
N2 - Musculoskeletal ultrasound (US) now thrives as an established imaging modality for the investigation and management of chronic inflammatory arthritis. We summarize here results of the Outcome Measures in Rheumatology (OMERACT) US working group (WG) projects of the last 2 years. These results were reported at the OMERACT 12 meeting at the plenary session and discussed during breakout sessions. Topics included standardization of US use in rheumatic disease over the last decade and its contribution to understanding musculoskeletal diseases. This is the first update report of WG activities in validating US as an outcome measure in musculoskeletal inflammatory and degenerative diseases, including pediatric arthritis, since the OMERACT 11 meeting.
AB - Musculoskeletal ultrasound (US) now thrives as an established imaging modality for the investigation and management of chronic inflammatory arthritis. We summarize here results of the Outcome Measures in Rheumatology (OMERACT) US working group (WG) projects of the last 2 years. These results were reported at the OMERACT 12 meeting at the plenary session and discussed during breakout sessions. Topics included standardization of US use in rheumatic disease over the last decade and its contribution to understanding musculoskeletal diseases. This is the first update report of WG activities in validating US as an outcome measure in musculoskeletal inflammatory and degenerative diseases, including pediatric arthritis, since the OMERACT 11 meeting.
KW - Arthritis, Psoriatic
KW - Arthritis, Rheumatoid
KW - Consensus Development Conferences as Topic
KW - Female
KW - Humans
KW - Joint erosions
KW - Male
KW - Netherlands
KW - Osteoarthritis
KW - Outcome Assessment, Health Care
KW - Outcome assessment
KW - Practice Guidelines as Topic
KW - Retrospective Studies
KW - Severity of Illness Index
KW - Ultrasonography
KW - Arthritis, Psoriatic
KW - Arthritis, Rheumatoid
KW - Consensus Development Conferences as Topic
KW - Female
KW - Humans
KW - Joint erosions
KW - Male
KW - Netherlands
KW - Osteoarthritis
KW - Outcome Assessment, Health Care
KW - Outcome assessment
KW - Practice Guidelines as Topic
KW - Retrospective Studies
KW - Severity of Illness Index
KW - Ultrasonography
UR - http://hdl.handle.net/10807/169085
U2 - 10.3899/jrheum.141462
DO - 10.3899/jrheum.141462
M3 - Article
SN - 0315-162X
VL - 42
SP - 2172
EP - 2176
JO - THE JOURNAL OF RHEUMATOLOGY
JF - THE JOURNAL OF RHEUMATOLOGY
ER -